Navigation Links
Ridge Diagnostics Wins Growth-Promoting Loan From Biotech Center
Date:7/10/2009

RESEARCH TRIANGLE PARK, N.C., July 10 /PRNewswire/ -- Ridge Diagnostics, Inc., a neurodiagnostic company with a first-in-class, proprietary blood test for Major Depressive Disorder (MDD), announced the award of a $202,500 loan from the North Carolina Biotechnology Center. The funds will further develop the company's CLIA certified laboratory in Research Triangle Park, thereby supporting the commercialization of its proprietary blood test for depression.

The award was made under the Biotechnology Center's Strategic Growth Loan (SGL) program, which helps promising North Carolina companies succeed in the challenging startup process.

"Ridge Diagnostics is a great example of why the loans from the North Carolina Biotechnology Center are so important," said John Richert, vice president for business and technology development at the North Carolina Biotechnology Center. "By helping them advance their technologies, we enable a strong company to grow stronger, bringing economic opportunity and the prospect of new jobs to the state."

This is the second SGL awarded to Ridge. The company is preparing to launch its multi-analyte blood test for diagnosing clinical depression and monitoring its therapy. The MDDScore(TM) provides objective, biological information associated with physiological changes caused by the condition. The test will be used by physicians to augment traditional diagnostic tools such as behavioral questionnaires and clinical assessments.

"Ridge Diagnostics, once again, would like to thank the NC Biotechnology Center for their ongoing support of the company," said Stan Sewitch, CEO. "By preparing our laboratory for commercial expansion, this Strategic Growth Loan allows us to offer our Clinical Experience Program to physicians and patients in North Carolina and other select areas of the United States."

The Ridge Clinical Experience Program, slated to begin in September, will enable practicing physicians to experience the benefits of the test as an aid in the diagnosis and management of patients with depression.

Ridge Diagnostics, Inc. is a neurodiagnostic company commercializing a breakthrough first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD). The company's products are based on a proprietary Human Biomarker Library and Hyper-Mapping(TM) analytical technology. Ridge intends to develop a comprehensive program of neuropsychiatric disease diagnostics. Ridge Diagnostics' tests are provided through its CLIA certified laboratory in North Carolina, with plans for diagnostic test kits sold worldwide. The company's research and clinical laboratories are headquartered in Research Triangle Park, NC, with administrative offices in San Diego, CA. www.RidgeDx.com

About the North Carolina Biotechnology Center

The Biotechnology Center, headquartered in Research Triangle Park, is a private, non-profit corporation supported by the NC General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.


'/>"/>
SOURCE Ridge Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
2. Massachusetts Employers and Health Plans Continue to Support Quality Care by Rewarding Physicians through Bridges to Excellence Programs
3. EPA Says Follow-Up Sampling Shows No PCB Risk at Park Ridge Elementary School
4. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
5. The Cambridge Group Names Two New Principals
6. Story tips from the Department of Energys Oak Ridge National Laboratory, Nov. 2007
7. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
8. Bridges to Excellence Announces New Implementation Programs for Health Plans and Additions to Board of Directors
9. Audio from Medialink and GlaxoSmithKline: Cleaning House ... Overhaul Your Fridge and Pantry to Lose Weight
10. Breckenridge Pharmaceutical Signs Long Term Agreement with Helm AG (Hamburg, Germany)
11. Breckenridge Pharmaceutical Settles Paragraph IV Litigation and Receives FDA Approval for its Oxcarbazepine ANDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... , ... June 28, 2017 , ... Anyone with a remote control has seen the ... do it, you the flipper will get rich in no time. But what about ... things can get for the buyer of a flipped house. An email recently sent ...
(Date:6/28/2017)... ... June 28, 2017 , ... David B. Sosin, a founding partner at ... over the post of 2nd Vice President for the Illinois State Bar Association , ... the ISBA’s 3rd Vice President in 2016 following a state-wide election and served in that ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the participation of Pure ... television series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET ... of garden pea seed. As demand grew, the small company located in Moscow, Idaho ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. (the “Company”) ... year study conducted by the University of Saskatchewan in partnership with PotashCorp, Agrium ... brine-impacted groundwater. As a part of the study, batch adsorption experiments were conducted ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner ... surrounding regions access to insurance assistance and financial planning services, is announcing the ... assist families in the region facing financial crisis. , Matthew 25: Ministries (M25M) ...
Breaking Medicine News(10 mins):
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
(Date:6/8/2017)... Fla. , June 8, 2017  Less than ... that hit more than 200,000 companies, including hospital networks, ... being heralded as one of the largest online extortion ... in the healthcare market, it is imperative that providers ... protect their data from this — and many other ...
(Date:6/7/2017)... Inc., (Nasdaq: NVAX ) today announced that data ... RSV F protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) ... the journal Vaccine (the data contained ... The Company previously announced top line results from ... F Vaccine with the goal of protecting infants from RSV ...
Breaking Medicine Technology: